still red today - hope green still today
APVO SHOULD RISING - YESTERDAY ALREADY $0.49
TIME TO BOUNCING , LET'S GOOOOO
Alliance Global Partners initiated coverage on Aptevo on October 9th, 2023 at $4.75/ share.
Thanks for the umpteenth update! Company has compounds proven efficacious vs. cancer/leukemia, that’s why it spiked to $70 a couple of years ago. If APVO runs in the near future, remember the warrants/ APVTW…
It really does need some good news but I've been nibbling at these cheap shares, I have some healthy positions in the warrants which should also skyrocket on upward moves of the commons
Poco a poco ( Little by little)
I added as well. Need news!!
I added in a few accounts as it dropped so news and parabolic would be fantastic
It’s going up! News could send this parabolic.
I'm up 40% on my few days of owning APVO - Hoping to hold til it gains me 300% or better.
I have a bunch of bait in the water for the warrants - I really want to add to what I gots.
I scarfed those .015s a while back after wildly overpaying close to $2. Might try a bid at .015..
Think I'll toss my NFLX gains from today into a split between commons and more warrants. I've already banked huge gains on the warrants way way back, like years ago I think.
Exactly, like today, home run news and it tanks. Why? Clearly being accumulated by deep pockets, because they know the science is tight. APTVW warrants are the high risk/ monster return play..
It never does for those that hold....
On December 12, 2022, Aptevo Therapeutics Inc. (“Aptevo” or the “Company”) announced that APVO436, in combination with venetoclax and azacytidine,
achieved a 100% clinical benefit rate in venetoclax treatment naïve AML patients. The data, which was presented in a poster session at the 64th American
Society of Hematology Annual Meeting and Exposition in New Orleans, also showed that APVO436, when given in combination with this standard-of-care
regimen, was observed to be generally safe and well tolerated.
Aptevo plans to initiate a Phase 2 trial in the second half of 2023 to further evaluate APVO436 in combination with venetoclax and azacitidine among frontline
and relapsed/refractory AML patients who are venetoclax treatment naïve.
APVO looking good today, up 25% on heavy volume. Two complete remissions. Bring back that $50 buyout offer!
Thanks 136. APVO's stock has gone straight down for over a year. Any near term catalysts that might turn things around? Any FDA decisions or trial results due soon?
Yeah it was something about a disagreement regarding an NDA
Also, the warrants are super cheap because the exercise price is $18.20
If APVO moves up significantly toward that… expect the warrants to start moving
I own a good chunk of this stock, so hopefully that happens
APVO really turned down a $50 offer? Unreal. Does anyone see value in the warrants? They are trading at .10, near an all time low. If another buyout or some solid news hits, they could be an easy 10 to 20x from here.
Why and when? Tia
APVO $$$$ EXPLODING BACK TO $20.00+..
You back in yet? $apvo low volume consolidation the past 3 sessions. Looking for bigger volume this week to determine trend direction. Not loving the lower low today from 2 days ago, but still much higher than the low we had last week on over 100 million in volume.
APVO $$$ SHOULD MOVE BIG NEXT WEEK..SHOULD BE TRADING AT $30.00+ AT LEAST !!!..